Logo image of AVTR

AVANTOR INC (AVTR) Stock Fundamental Analysis

NYSE:AVTR - US05352A1007 - Common Stock

12.98 USD
-0.31 (-2.33%)
Last: 9/3/2025, 2:48:47 PM
Fundamental Rating

4

AVTR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 55 industry peers in the Life Sciences Tools & Services industry. AVTR has a medium profitability rating, but doesn't score so well on its financial health evaluation. AVTR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year AVTR was profitable.
AVTR had a positive operating cash flow in the past year.
In the past 5 years AVTR has always been profitable.
AVTR had a positive operating cash flow in each of the past 5 years.
AVTR Yearly Net Income VS EBIT VS OCF VS FCFAVTR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

The Return On Assets of AVTR (5.38%) is better than 78.18% of its industry peers.
AVTR has a better Return On Equity (10.94%) than 81.82% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.69%, AVTR is in the better half of the industry, outperforming 69.09% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AVTR is significantly below the industry average of 15.96%.
Industry RankSector Rank
ROA 5.38%
ROE 10.94%
ROIC 4.69%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
AVTR Yearly ROA, ROE, ROICAVTR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30 -40

1.3 Margins

AVTR has a better Profit Margin (10.31%) than 76.36% of its industry peers.
AVTR's Profit Margin has improved in the last couple of years.
AVTR's Operating Margin of 8.89% is fine compared to the rest of the industry. AVTR outperforms 65.45% of its industry peers.
In the last couple of years the Operating Margin of AVTR has grown nicely.
AVTR's Gross Margin of 33.25% is on the low side compared to the rest of the industry. AVTR is outperformed by 65.45% of its industry peers.
In the last couple of years the Gross Margin of AVTR has remained more or less at the same level.
Industry RankSector Rank
OM 8.89%
PM (TTM) 10.31%
GM 33.25%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
AVTR Yearly Profit, Operating, Gross MarginsAVTR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVTR is destroying value.
Compared to 1 year ago, AVTR has more shares outstanding
Compared to 5 years ago, AVTR has more shares outstanding
Compared to 1 year ago, AVTR has an improved debt to assets ratio.
AVTR Yearly Shares OutstandingAVTR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AVTR Yearly Total Debt VS Total AssetsAVTR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

AVTR has an Altman-Z score of 1.76. This is a bad value and indicates that AVTR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.76, AVTR is in line with its industry, outperforming 50.91% of the companies in the same industry.
The Debt to FCF ratio of AVTR is 7.63, which is on the high side as it means it would take AVTR, 7.63 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 7.63, AVTR is doing good in the industry, outperforming 61.82% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that AVTR is not too dependend on debt financing.
AVTR's Debt to Equity ratio of 0.48 is on the low side compared to the rest of the industry. AVTR is outperformed by 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.63
Altman-Z 1.76
ROIC/WACC0.48
WACC9.84%
AVTR Yearly LT Debt VS Equity VS FCFAVTR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

AVTR has a Current Ratio of 0.98. This is a bad value and indicates that AVTR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.98, AVTR is not doing good in the industry: 89.09% of the companies in the same industry are doing better.
AVTR has a Quick Ratio of 0.98. This is a bad value and indicates that AVTR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AVTR (0.67) is worse than 92.73% of its industry peers.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.67
AVTR Yearly Current Assets VS Current LiabilitesAVTR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.09% over the past year.
The earnings per share for AVTR have been decreasing by -10.82% on average. This is quite bad
AVTR shows a decrease in Revenue. In the last year, the revenue decreased by -2.34%.
The Revenue has been growing slightly by 2.35% on average over the past years.
EPS 1Y (TTM)3.09%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-4%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-1.14%

3.2 Future

AVTR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.29% yearly.
The Revenue is expected to grow by 3.40% on average over the next years.
EPS Next Y-3.4%
EPS Next 2Y2.24%
EPS Next 3Y5.56%
EPS Next 5Y10.29%
Revenue Next Year-2.86%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.2%
Revenue Next 5Y3.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AVTR Yearly Revenue VS EstimatesAVTR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
AVTR Yearly EPS VS EstimatesAVTR Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.98, the valuation of AVTR can be described as correct.
Based on the Price/Earnings ratio, AVTR is valued cheaper than 98.18% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.90. AVTR is valued rather cheaply when compared to this.
AVTR is valuated correctly with a Price/Forward Earnings ratio of 12.42.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AVTR indicates a rather cheap valuation: AVTR is cheaper than 94.55% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.52, AVTR is valued a bit cheaper.
Industry RankSector Rank
PE 12.98
Fwd PE 12.42
AVTR Price Earnings VS Forward Price EarningsAVTR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AVTR indicates a rather cheap valuation: AVTR is cheaper than 96.36% of the companies listed in the same industry.
87.27% of the companies in the same industry are more expensive than AVTR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.92
EV/EBITDA 12.88
AVTR Per share dataAVTR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4 6 8

4.3 Compensation for Growth

AVTR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.24%
EPS Next 3Y5.56%

More info and screens

0

5. Dividend

5.1 Amount

AVTR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANTOR INC

NYSE:AVTR (9/3/2025, 2:48:47 PM)

12.98

-0.31 (-2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)10-23 2025-10-23/bmo
Inst Owners99.28%
Inst Owner Change3.51%
Ins Owners0.3%
Ins Owner Change19.84%
Market Cap8.85B
Analysts73.79
Price Target14.29 (10.09%)
Short Float %5.07%
Short Ratio2.45
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.72%
Min EPS beat(2)-5.09%
Max EPS beat(2)-2.36%
EPS beat(4)2
Avg EPS beat(4)-0.99%
Min EPS beat(4)-5.09%
Max EPS beat(4)2.94%
EPS beat(8)5
Avg EPS beat(8)1.75%
EPS beat(12)7
Avg EPS beat(12)1.06%
EPS beat(16)10
Avg EPS beat(16)1.82%
Revenue beat(2)0
Avg Revenue beat(2)-2.51%
Min Revenue beat(2)-3.57%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-2.72%
Min Revenue beat(4)-3.57%
Max Revenue beat(4)-1.44%
Revenue beat(8)0
Avg Revenue beat(8)-2.07%
Revenue beat(12)0
Avg Revenue beat(12)-2.21%
Revenue beat(16)0
Avg Revenue beat(16)-2.27%
PT rev (1m)-16.69%
PT rev (3m)-18.02%
EPS NQ rev (1m)-15.29%
EPS NQ rev (3m)-18.28%
EPS NY rev (1m)-7.75%
EPS NY rev (3m)-7.81%
Revenue NQ rev (1m)-2.78%
Revenue NQ rev (3m)-1.52%
Revenue NY rev (1m)-1.01%
Revenue NY rev (3m)-0.98%
Valuation
Industry RankSector Rank
PE 12.98
Fwd PE 12.42
P/S 1.33
P/FCF 15.92
P/OCF 12.98
P/B 1.41
P/tB N/A
EV/EBITDA 12.88
EPS(TTM)1
EY7.7%
EPS(NY)1.05
Fwd EY8.05%
FCF(TTM)0.82
FCFY6.28%
OCF(TTM)1
OCFY7.7%
SpS9.78
BVpS9.22
TBVpS-4.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.38%
ROE 10.94%
ROCE 5.81%
ROIC 4.69%
ROICexc 4.91%
ROICexgc 74.82%
OM 8.89%
PM (TTM) 10.31%
GM 33.25%
FCFM 8.34%
ROA(3y)4.42%
ROA(5y)3.49%
ROE(3y)10.57%
ROE(5y)9.15%
ROIC(3y)6.58%
ROIC(5y)6.55%
ROICexc(3y)6.76%
ROICexc(5y)6.74%
ROICexgc(3y)52.77%
ROICexgc(5y)49.06%
ROCE(3y)8.14%
ROCE(5y)8.11%
ROICexcg growth 3Y9.06%
ROICexcg growth 5Y15.03%
ROICexc growth 3Y-3.1%
ROICexc growth 5Y1.59%
OM growth 3Y-7.05%
OM growth 5Y2.19%
PM growth 3Y15.1%
PM growth 5YN/A
GM growth 3Y-0.28%
GM growth 5Y1.11%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 7.63
Debt/EBITDA 2.99
Cap/Depr 31.03%
Cap/Sales 1.89%
Interest Coverage 3.4
Cash Conversion 68.32%
Profit Quality 80.87%
Current Ratio 0.98
Quick Ratio 0.67
Altman-Z 1.76
F-Score5
WACC9.84%
ROIC/WACC0.48
Cap/Depr(3y)35.33%
Cap/Depr(5y)30.17%
Cap/Sales(3y)2.02%
Cap/Sales(5y)1.71%
Profit Quality(3y)143.28%
Profit Quality(5y)453.06%
High Growth Momentum
Growth
EPS 1Y (TTM)3.09%
EPS 3Y-10.82%
EPS 5YN/A
EPS Q2Q%-4%
EPS Next Y-3.4%
EPS Next 2Y2.24%
EPS Next 3Y5.56%
EPS Next 5Y10.29%
Revenue 1Y (TTM)-2.34%
Revenue growth 3Y-2.8%
Revenue growth 5Y2.35%
Sales Q2Q%-1.14%
Revenue Next Year-2.86%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.2%
Revenue Next 5Y3.4%
EBIT growth 1Y-17.23%
EBIT growth 3Y-9.65%
EBIT growth 5Y4.59%
EBIT Next Year3.61%
EBIT Next 3Y4.81%
EBIT Next 5Y8.1%
FCF growth 1Y-22.89%
FCF growth 3Y-6.35%
FCF growth 5Y18.01%
OCF growth 1Y-19.94%
OCF growth 3Y-4.11%
OCF growth 5Y18.89%